FDA Clearance Tracker · K173495
Single Use Hot Biopsy Forceps FD-231
Last checked: Nov 20, 2026Latest source record: Nov 30, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Nov 30, 2018
Substantially Equivalent
Time to decision
382 days
Received Nov 13, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K173495
- Device name
- Single Use Hot Biopsy Forceps FD-231
- Applicant
- Olympus Medical Systems Corp.
- Applicant location
- Hachioji-Shi, JP
- Received
- Nov 13, 2017
- Decided
- Nov 30, 2018
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 876.4300
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QEC (Forceps, Biopsy, Electric Surgical Hemostasis Within Tracheobronchial Tree).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K173495
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Olympus Medical Systems Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262079 · Decided Sep 10, 2026 · 80 days after receipt
Device type: Endoscopic Video Imaging System/Component, Gastroenterology-Urology (FET) · GI, Urology & Nephrology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.